Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/WCO.0000000000000094 http://scihub22266oqcxt.onion/10.1097/WCO.0000000000000094 C4132635!4132635!24722325     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Opin+Neurol 2014 ; 27 (3): 271-8 Nephropedia Template TP {{tp|p=24722325|t=2014. Relapsing and progressive forms of multiple sclerosis ? insights from pathology |pdf=|usr=}}{{24722325}} gab.com Text Relapsing and progressive forms of multiple sclerosis insights from pathology JO: Curr Opin Neurol http://www.kidney.de/pget.php?&tw=1&pmid=24722325 #FOAvip PURPOSE OF THIS REVIEW: The predominant clinical disease course of multiple sclerosis (MS) starts with reversible episodes of neurological disability, which transforms into progressive neurological decline. This review provides insight into the pathological differences during relapsing and progressive phases of MS. RECENT FINDINGS: The clinical course of MS is variable and the disease can be classified into relapsing and progressive phases. Pathological studies have been successful in distinguishing between these two forms of the disease and correlate with the clinical findings in terms of cellular responses, the inflammatory environment, and the location of lesions. SUMMARY: Available therapies for MS patients, while effective during the relapsing phase, have little benefit for progressive MS patients. Development of therapies to benefit progressive MS patients will require a better understanding of the pathogenesis of progressive MS. This review discusses and compares the pathological findings in relapsing and progressive MS patients. Twit Text FOAVip Relapsing and progressive forms of multiple sclerosis insights from pathology ????Curr Opin Neurol http://www.kidney.de/pget.php?&tw=1&pmid=24722325 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24722325 #FOAvip English Wikipedia <ref>{{Cite pmid|24722325}}</ref> Relapsing and progressive forms of multiple sclerosis ? insights from pathology #MMPMID24722325 Dutta R; Trapp BD Curr Opin Neurol 2014[Jun]; 27 (3): 271-8 PMID24722325show ga PURPOSE OF THIS REVIEW: The predominant clinical disease course of multiple sclerosis (MS) starts with reversible episodes of neurological disability, which transforms into progressive neurological decline. This review provides insight into the pathological differences during relapsing and progressive phases of MS. RECENT FINDINGS: The clinical course of MS is variable and the disease can be classified into relapsing and progressive phases. Pathological studies have been successful in distinguishing between these two forms of the disease and correlate with the clinical findings in terms of cellular responses, the inflammatory environment, and the location of lesions. SUMMARY: Available therapies for MS patients, while effective during the relapsing phase, have little benefit for progressive MS patients. Development of therapies to benefit progressive MS patients will require a better understanding of the pathogenesis of progressive MS. This review discusses and compares the pathological findings in relapsing and progressive MS patients. äRelapsing and progressive forms of multiple sclerosis ? insights from (epmc).pdf DeepDyve Pubget Overpricing